Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IVIG 10% TVR in Chronic ITP
NCT00162006Phase 2Completed
- Sponsor
- Takeda
- Start
- Jan 2003
- Primary completion
- Dec 2003
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 4
01
Overview
A Phase 2 trial of intravenous immunoglobulin G in immune thrombocytopenia (ITP), sponsored by Takeda. Started Jan 2003; status: completed.
02
Drugs
intravenous immunoglobulin G
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on NCT00162006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00162006.